Richard Rosenquist Selected Research

ibrutinib

1/2023	BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib.
1/2019	Long-term real-world results of ibrutinib therapy in patients with relapsed or refractory chronic lymphocytic leukemia: 30-month follow up of the Swedish compassionate use cohort.
5/2018	A novel ex vivo high-throughput assay reveals antiproliferative effects of idelalisib and ibrutinib in chronic lymphocytic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard Rosenquist Research Topics

Disease

70	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2024 - 03/2002
39	Neoplasms (Cancer) 03/2023 - 11/2002
20	Lymphoma (Lymphomas) 11/2023 - 05/2004
11	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2019 - 04/2002
9	Pain (Aches) 01/2023 - 01/2010
9	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 06/2005
8	Disease Progression 10/2022 - 08/2004
7	B-Cell Lymphoma (Lymphoma, B Cell) 11/2023 - 04/2007
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 10/2002
6	Leukemia 01/2021 - 01/2005
4	Rheumatoid Arthritis 01/2017 - 04/2008
3	Hematologic Neoplasms (Hematological Malignancy) 10/2023 - 10/2021
3	Trisomy (Trisomies) 10/2023 - 08/2003
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2017 - 12/2009
3	Residual Neoplasm 01/2017 - 10/2002
3	Burns 03/2014 - 01/2010
2	Microsatellite Instability 05/2024 - 01/2024
2	Inflammation (Inflammations) 11/2023 - 02/2014
2	Chronic Pain 04/2023 - 01/2023
2	Low Back Pain (Lumbago) 01/2023 - 11/2016
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 09/2009
2	Blister (Bulla) 11/2014 - 04/2008
2	Wounds and Injuries (Trauma) 01/2012 - 07/2004
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 07/2005 - 01/2005
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 07/2023
1	T-Cell Lymphoma (Lymphoma, T Cell) 07/2023
1	Substance-Related Disorders (Drug Abuse) 04/2023
1	Medulloblastoma 03/2023
1	Hodgkin Disease (Hodgkin's Disease) 01/2021
1	Postoperative Pain 01/2020

Drug/Important Bio-Agent (IBA)

38	Immunoglobulins (Immunoglobulin)IBA 02/2024 - 03/2002
29	AntigensIBA 01/2019 - 04/2002
11	Proteins (Proteins, Gene)FDA Link 10/2022 - 02/2008
9	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2005
7	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2018 - 11/2002
6	RNA (Ribonucleic Acid)IBA 01/2023 - 08/2011
5	Opioid Analgesics (Opioids)IBA 04/2023 - 01/2010
5	DNA (Deoxyribonucleic Acid)IBA 03/2023 - 06/2009
5	Immunoglobulin Variable RegionIBA 07/2005 - 04/2003
4	Complement System Proteins (Complement)IBA 11/2022 - 01/2012
4	Complementarity Determining Regions (Complementarity Determining Region)IBA 01/2019 - 02/2004
4	Immunoglobulin M (IgM)IBA 01/2019 - 07/2005
4	EpitopesIBA 01/2016 - 06/2003
3	ibrutinibIBA 01/2023 - 05/2018
3	fludarabineIBA 12/2019 - 02/2016
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2016 - 10/2002
3	Messenger RNA (mRNA)IBA 06/2015 - 02/2008
2	Transcription Factors (Transcription Factor)IBA 11/2023 - 06/2010
2	ChromatinIBA 11/2023 - 12/2013
2	ChemokinesIBA 10/2023 - 01/2021
2	NucleotidesIBA 03/2023 - 01/2023
2	Cell-Free Nucleic AcidsIBA 03/2023 - 01/2023
2	Circulating Tumor DNAIBA 01/2023 - 11/2022
2	Gabapentin (Neurontin)FDA LinkGeneric 01/2020 - 03/2014
2	Rituximab (Mabthera)FDA Link 12/2019 - 02/2016
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2019 - 02/2016
2	Amino Acids FDA Link 01/2017 - 02/2004
2	MicroRNAs (MicroRNA)IBA 01/2016 - 06/2014
2	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2015 - 04/2010
2	AntibodiesIBA 11/2014 - 04/2008
2	AutoantigensIBA 11/2014 - 05/2004
2	Antigen Receptors (Antigen Receptor)IBA 08/2013 - 08/2009
2	SteroidsIBA 01/2012 - 04/2010
2	MitogensIBA 07/2005 - 08/2003
2	Surface Antigens (Surface Antigen)IBA 07/2005 - 01/2003
2	Indicators and Reagents (Reagents)IBA 04/2005 - 08/2004
1	InterferonsIBA 11/2023
1	Nucleic AcidsIBA 01/2023
1	Complementary RNA (cRNA)IBA 01/2023
1	ProteomeIBA 10/2022
1	Genetic Markers (Genetic Marker)IBA 01/2022
1	3- (5- amino- 2- methyl- 4- oxoquinazolin- 3(4H)- yl)piperidine- 2,6- dioneIBA 01/2021
1	ribosomal protein S15IBA 01/2021
1	IgKIBA 01/2021
1	Lidocaine (Xylocaine)FDA LinkGeneric 01/2020
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2020
1	Analgesics (Analgesic Drugs)IBA 01/2020
1	PlacebosIBA 01/2020
1	Non-Narcotic Analgesics (Analgesics, Non Narcotic)IBA 01/2020
1	Ketamine FDA LinkGeneric 01/2020
1	Morphine (MS Contin)FDA LinkGeneric 01/2020
1	venetoclaxIBA 10/2019
1	Opiate AlkaloidsIBA 01/2019
1	serum P-component (CIt)IBA 01/2019
1	idelalisibIBA 05/2018
1	Biocompatible Materials (Biomaterials)IBA 02/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2018

Therapy/Procedure

26	Therapeutics 05/2024 - 05/2004
5	Precision Medicine 10/2023 - 01/2022
5	Pain Management 04/2023 - 03/2014
3	Drug Therapy (Chemotherapy) 01/2018 - 11/2002
3	Analgesia 03/2014 - 07/2004
1	Immunotherapy 05/2024
1	Breast Implants (Breast Implant) 07/2023
1	Perioperative Care 04/2023
1	Biological Therapy 01/2023
1	Spinal Cord Stimulation 01/2023
1	Conduction Anesthesia (Regional Anesthesia) 07/2022
1	Genomic Medicine 01/2022
1	Palliative Care (Palliative Therapy) 11/2021